- decreased hematocrit / IMPC
- decreased leukocyte cell number / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating glycerol level / IMPC
- increased lean body mass / IMPC
- improved glucose tolerance / IMPC
- abnormal humerus morphology / IMPC
- increased circulating amylase level / IMPC
- decreased total body fat amount / IMPC
C57BL/6N-Cibar1tm1b(KOMP)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:14247 |
International strain name | C57BL/6N-Cibar1tm1b(KOMP)Wtsi/WtsiOrl |
Alternative name | EPD0804_2_A04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cibar1tm1b(KOMP)Wtsi |
Gene/Transgene symbol | Cibar1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0804_2_A04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on KOMP final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Postaxial polydactyly type A / Orphanet_93334
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating glycerol level / IMPC
- decreased hemoglobin content / IMPC
- abnormal humerus morphology / IMPC
- decreased total body fat amount / IMPC
- increased lean body mass / IMPC
- decreased leukocyte cell number / IMPC
- decreased hematocrit / IMPC
- increased circulating amylase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased erythrocyte cell number / IMPC
- improved glucose tolerance / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).